Lisowska, M.; Milczarek, M.; Ciekot, J.; Kutkowska, J.; Hildebrand, W.; Rapak, A.; Miazek, A.
An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma. Cancers 2019, 11, 1438.
https://doi.org/10.3390/cancers11101438
AMA Style
Lisowska M, Milczarek M, Ciekot J, Kutkowska J, Hildebrand W, Rapak A, Miazek A.
An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma. Cancers. 2019; 11(10):1438.
https://doi.org/10.3390/cancers11101438
Chicago/Turabian Style
Lisowska, Marta, Magdalena Milczarek, Jarosław Ciekot, Justyna Kutkowska, Wojciech Hildebrand, Andrzej Rapak, and Arkadiusz Miazek.
2019. "An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma" Cancers 11, no. 10: 1438.
https://doi.org/10.3390/cancers11101438
APA Style
Lisowska, M., Milczarek, M., Ciekot, J., Kutkowska, J., Hildebrand, W., Rapak, A., & Miazek, A.
(2019). An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma. Cancers, 11(10), 1438.
https://doi.org/10.3390/cancers11101438